The epidermal differentiation complex (EDC) contains a large number of gene products which are crucial for the maturation of the human epidermis and can contribute to skin diseases, even carcinogenesis. It is generally accepted that activation of oncogenes and/or inactivation of tumor suppressor genes play pivotal roles in the process of carcinogenesis. Here, NICE-3, a novel EDC gene, was found to be up-regulated in human hepatocellular carcinoma ( 
Introduction
According to liver cancer incidence and mortality It is generally known that activation of oncogenes or inactivation of tumor suppressor genes is crucial to carcinogenesis. For the past few years, our laboratory had found many up-regulated or down-regulated genes NICE-3 is a novel member of the epidermal of genes which are crucial for the maturation of the human epidermis and contribute to skin diseases, even + hematopoietic stem/progenitor that NICE-3 could be transactivated by hepatitis C whether NICE-3 is up-regulated in the typical HCC and the up-regulation of NICE-3 could contribute to the hepatocarcinogenesis. In this study, we found that NICE-3 was markedly up-regulated in HCC tissue specimens compared with correspondingly noncancerous tissues by recombinant plasmids and knockdown of endogenous NICE-3 by RNA interference, further demonstrated that up-regulation of NICE-3 could contribute to candidate oncogene of HCC.
Materials and Methods
All 40 paired HCC tissue specimens were obtained from the patients who were diagnosed HCC and accepted hepatectomies in the department of hepatobiliary surgery signed informed consents and this research program was Genome Center.
of NICE-3. Fifteen liver tumor-derived cell lines 2 product for NICE-3, we used the following primers: internal reference. Furthermore, the relative mRNA level of NICE-3 in HCC specimens and Liver cancer cell were repeated independently at least 3 times to guarantee
First of all,we designed a pair of primer with double not targeting any annotated human genes to use as a to chronically silence NICE-3, we constructed the DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4363 Up-regulation of NICE-3 Could Contribute to Human HCC these shRNAs were described as follows: shRNA-NC, -For transfection, cells were plated in 6-wells plates at according to the protocols recommended by the manufacturer.
shRNA-936) plasmids were cultured in the medium added resistant cells were used as our stable cell Lines.
repeated at least three times. 3 until forming visible clones. Finally, these cell colonies were stained with coomassie brilliant blue, photographed and counted.
anchorage-independent growth, the soft agar colony 3 Lastly the cell colonies in soft agar were photographed independently repeated at least three times.
were then transferred to a polyvinylidene difluoride at room temperature, the membrane was incubated with day,incubation with the secondary antibody at room temperature for 2 hours was in the same way. Finally, the record the electrophoretic bands. showed that NICE-3 knockdown could cause a arrest of oncogenesis and progression. NICE-3 is also known as time. Furthermore, cell cycle analysis indicated that NICE-3 knockdown may inhibit cell proliferation via causing contribution to HCC still need our further investigation.
